Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
A myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...